Chromosomal imbalances in gastric and esophageal adenocarcinoma: Specific comparative genomic hybridization–detected abnormalities segregate with junctional adenocarcinomas

The incidence of adenocarcinoma arising at the esophagogastric junction (EGJ) is increasing at a rate greater than that for any other form of solid malignancy. Commensurate with this, the incidence of histologically similar tumors arising in the gastric body and antral mucosa is declining. The increased incidence of the proximal group of tumors may reflect, in part, the higher prevalence of Barrett esophagus. These epidemiological features suggest that histologically similar tumors arising at the EGJ and from the distal stomach are different, which may be reflected in the genetic abnormalities that characterize the two groups of tumors. The purpose of this study was to screen genomic DNA from adenocarcinomas of the esophagus and stomach for regions of chromosomal imbalance, using comparative genomic hybridization to determine whether tumors at the EGJ (junctional tumors) have a different profile compared with tumors of the distal stomach. Tumor samples were derived from a series of 48 gastroesophageal adenocarcinomas (20 junctional and 28 distal) that were acquired prospectively from patients undergoing esophagogastrectomy. These tumors are characterized by several regions of chromosomal imbalance with no obvious correlation between most regions of abnormal copy number and tumor type. However, our study shows for the first time cytogenetic abnormalities (5p+ and 18q−) that identify statistically significant differences (P < 0.02 and < 0.05, respectively) between junctional and distal gastric tumors. These differences are gain of 5p (55% [11/20] of junctional tumors vs. 21% [6/28] of distal gastric tumors) and loss of 18q (25% [5/20] cases of junctional tumors vs. 4% [1/28] of distal tumors) segregating with tumors of the EGJ. These abnormalities may distinguish distinct tumor subtypes that are recognized in epidemiological and clinical studies but that are otherwise histologically identical. © 2001 Wiley‐Liss, Inc.

[1]  D. Pinkel,et al.  Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors , 2022 .

[2]  H. McLeod,et al.  Comparative genomic hybridization and chromosomal instability in solid tumours , 1999, British Journal of Cancer.

[3]  P. Laurén,et al.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. , 1965, Acta pathologica et microbiologica Scandinavica.

[4]  H. Tanke,et al.  Comparative genomic hybridization of cancer of the gastroesophageal junction: deletion of 14Q31-32.1 discriminates between esophageal (Barrett's) and gastric cardia adenocarcinomas. , 1999, Cancer research.

[5]  J Piper,et al.  Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors , 1994, Genes, chromosomes & cancer.

[6]  D. Kerr,et al.  Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. , 1999, The American journal of pathology.

[7]  J. Fraumeni,et al.  Rising incidence of adenocarcinoma of the esophagus and gastric cardia. , 1991, JAMA.

[8]  C. Moskaluk,et al.  Comparative genomic hybridization of esophageal and gastroesophageal adenocarcinomas shows consensus areas of DNA gain and loss , 1998, Genes, chromosomes & cancer.

[9]  A R Zinsmeister,et al.  Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. , 1993, Gastroenterology.

[10]  A. Hagemeijer,et al.  Cytogenetic analysis of Barrett's mucosa and adenocarcinoma of the distal esophagus and cardia. , 1996, Cancer genetics and cytogenetics.

[11]  C. Stadtländer,et al.  Molecular epidemiology, pathogenesis and prevention of gastric cancer. , 1999, Carcinogenesis.

[12]  S. Knuutila,et al.  17q12‐21 amplicon, a novel recurrent genetic change in intestinal type of gastric carcinoma: A comparative genomic hybridization study , 1997, Genes, chromosomes & cancer.

[13]  E. Alcini,et al.  Benign and malignant epithelial tumors of the gastroenteric tract. Chromosome analysis in study and diagnosis , 1968, Cancer.

[14]  Carissa A. Sanchez,et al.  Evolution of neoplastic cell lineages in Barrett oesophagus , 1999, Nature Genetics.

[15]  C. Fenoglio-Preiser,et al.  The molecular biology of esophageal and gastric cancer and their precursors: oncogenes, tumor suppressor genes, and growth factors. , 1994, Human pathology.

[16]  S. Kern,et al.  Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma. , 1996, Cancer research.

[17]  N. Tsuchida,et al.  Changes in DNA copy number in primary gastric carcinomas by comparative genomic hybridization. , 1997, Clinical Cancer Research.

[18]  S. Hamilton,et al.  Genetic alterations in Barrett esophagus and adenocarcinomas of the esophagus and esophagogastric junction region. , 1998, The American journal of pathology.

[19]  H. Stützer,et al.  Proximal compared with distal adenocarcinoma of the stomach: Differences and consequences , 1991, The British journal of surgery.

[20]  D. Johnston,et al.  Increasing incidence of Barrett's oesophagus: education, enthusiasm, or epidemiology? , 1997, The Lancet.

[21]  J. Weber,et al.  Barrett's oesophagus: Microsatellite analysis provides evidence to support the proposed metaplasia‐dysplasia‐carcinoma sequence , 1998, Genes, chromosomes & cancer.

[22]  C. McConkey,et al.  Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. , 1990, British Journal of Cancer.

[23]  M. Hendrix,et al.  Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. , 1994, Science.

[24]  Carissa A. Sanchez,et al.  Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms. , 1996, Oncogene.

[25]  Seung-Moo Noh,et al.  Genetic alterations of gastric cancer: comparative genomic hybridization and fluorescence In situ hybridization studies. , 2000, Cancer genetics and cytogenetics.